Clinical Trial Update: Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3

View source ↗

Summary

Clinical trial update examining the role of Human Neutrophil Peptide-1 to 3 in periprocedural myocardial infarction related to coronary thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Thrombosis

Drugs mentioned

• Human Neutrophil Peptide-1 to 3 (Human neutrophil peptide-1 to 3)

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Coronary Thrombosis | Status: UNKNOWN